|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.420 USD | +1.57% |
|
+0.24% | -27.60% |
| 07/07 | RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating | MT |
| 03/07 | CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer | MT |
Business description: CorMedix Inc.
Number of employees: 191
Sales by Activity: CorMedix Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Drug Product | 2L | 65.41T | - | 4.35Cr | 31Cr |
Geographical breakdown of sales: CorMedix Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States | - | - | - | - | 31Cr |
Germany | 2L | 65.41T | - | - | - |
Executive Committee: CorMedix Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 50 | 10/05/2022 |
Susan Blum
DFI | Director of Finance/CFO | 54 | 29/08/2025 |
| Compliance Officer | 66 | 12/12/2023 | |
Tushar Mukherjee
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Chief Operating Officer | 47 | - |
Composition of the Board of Directors: CorMedix Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Janet Dillione
BRD | Director/Board Member | 67 | 06/08/2015 |
Myron Kaplan
CHM | Chairman | 81 | 03/08/2017 |
Steven Lefkowitz
BRD | Director/Board Member | 70 | 16/08/2011 |
Alan Dunton
BRD | Director/Board Member | 72 | 01/03/2019 |
Gregory Duncan
BRD | Director/Board Member | 61 | 02/11/2020 |
Joseph Todisco
CHM | Chairman | 50 | 08/01/2026 |
Robert Stewart
BRD | Director/Board Member | 59 | 13/04/2023 |
Holdings: CorMedix Inc.
| Name | Stocks | % | Valuation |
|---|---|---|---|
TALPHERA, INC. 18.16% | 90,90,909 | 18.16% | 9 M $ |
Company details: CorMedix Inc.
Specialty & Advanced Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.57% | +0.24% | -23.94% | +117.57% | 66Cr | |
| -0.10% | +3.21% | +56.40% | +20.77% | 31TCr | |
| -1.20% | -2.43% | +22.19% | -8.40% | 6.78TCr | |
| +0.35% | +2.11% | +34.61% | +93.22% | 922.93Cr | |
| +0.34% | +0.51% | +4.67% | +0.09% | 855.86Cr | |
| +1.53% | -3.64% | -22.99% | +3.93% | 418.16Cr | |
| -11.03% | -12.07% | -5.25% | +15.98% | 359.46Cr | |
| +1.87% | +3.36% | -47.86% | +27.51% | 355.05Cr | |
| -0.35% | -0.87% | +43.02% | +63.23% | 278.82Cr | |
| -7.41% | -2.37% | +3.82% | -22.47% | 208.92Cr | |
| Average | -1.44% | -1.52% | +6.47% | +31.14% | 4.17TCr | |
| Weighted average by Cap. | -0.36% | +1.02% | +46.61% | +17.28% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRMD Stock
- Company CorMedix Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition